Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure?

Eur Heart J. 2022 Dec 1;43(45):4754-4757. doi: 10.1093/eurheartj/ehac417.

Authors

Bertram Pitt¹, Deepak L Bhatt², Marco Metra³

Affiliations

¹ Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA.
² Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston, MA, USA.
³ Cardiology, ASST Spedali Civili and Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.

No abstract available

MeSH terms

Blood Glucose
Heart Failure* / drug therapy
Heart Failure* / prevention & control
Humans
Sodium-Glucose Transporter 2

Substances

Sodium-Glucose Transporter 2
Blood Glucose